Skip to main contentSkip to navigation
Sirius Investors

BEAT Stock: HeartBeam, Inc. Stock Price, Analysis & Insights

Get live beat stock price $2.52, comprehensive HeartBeam, Inc. stock analysis, charts, news, and expert forecast. Real-time beat stock data and investment insights.

2.52
62.65%Today
BEATHeartBeam, Inc. • NASDAQ Capital Market • Healthcare
Market Cap
86.65M
Volume
124.33M
52W High
3.48
52W Low
0.54

Loading chart...

Company Overview

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.

Company Information

CEO
Robert Eno
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Employees
21

Contact Information

Address
2118 Walsh Avenue
Country
US

Investment Analysis & Business Insights

Healthcare
Medical - Healthcare Information Services

Investment Highlights

Strong presence in the Healthcare sector with established market position

Lower volatility stock (Beta: -0.58) may provide portfolio stability

Business Model & Strategy

HeartBeam, Inc. operates in the Medical - Healthcare Information Services industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Robert Eno, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Medical - Healthcare Information Services model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.

Market Position & Competitive Landscape

HeartBeam, Inc. competes in the Medical - Healthcare Information Services within the broader Healthcare. With 86.6 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Capital Market, HeartBeam, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating HeartBeam, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for HeartBeam, Inc. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for HeartBeam, Inc.
  • Investors should consider how HeartBeam, Inc. fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

86.65M

P/E Ratio

-3.82

Beta

-0.58

Investment Analysis & Insights

Key Investment Highlights

  • Market Position: Healthcare leader with 86.65M market capitalization
  • Trading Volume: 124.33M shares traded today
  • Price Range: 52-week range of $0.54 - $3.48
  • Exchange: Listed on NASDAQ Capital Market

Financial Metrics

P/E Ratio:-3.82
EPS:$-0.66
Beta:-0.58
Avg Volume:6.54M

Market Analysis for HeartBeam, Inc.

HeartBeam, Inc. (BEAT) operates in the Medical - Healthcare Information Services industry within the Healthcare sector. With a current market capitalization of 86.65M, the company represents a significant player in its market. The stock is currently trading at $2.52 with a positivedaily change of 62.65%.

The company's 21 employee base and presence on the NASDAQ Capital Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -3.82, beta of -0.58, and 52-week price range from $0.54 to $3.48when evaluating investment opportunities.

Why Invest in HeartBeam, Inc.?

Strengths
  • • Established market presence in Healthcare
  • • Strong financial metrics and market position
  • • Listed on major exchange (NASDAQ Capital Market)
  • • Experienced leadership under Robert Eno
Investment Considerations
  • • Monitor sector-specific market trends
  • • Track quarterly earnings performance
  • • Consider market volatility and beta
  • • Evaluate long-term growth potential

Related Healthcare Stocks

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.